These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35882835)

  • 1. Reduction of primary graft dysfunction using cytokine adsorption during organ preservation and after lung transplantation.
    Ghaidan H; Stenlo M; Niroomand A; Mittendorfer M; Hirdman G; Gvazava N; Edström D; Silva IAN; Broberg E; Hallgren O; Olm F; Wagner DE; Pierre L; Hyllén S; Lindstedt S
    Nat Commun; 2022 Jul; 13(1):4173. PubMed ID: 35882835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended post-ex vivo lung perfusion cold preservation predicts primary graft dysfunction and mortality: Results from a multicentric study.
    Leiva-Juárez MM; Urso A; Arango Tomás E; Lederer DJ; Sanchez P; Griffith B; Davis RD; Daneshmand M; Hartwig M; Cantu E; Weyant MJ; Bermudez C; D'Cunha J; Machuca T; Wozniak T; Lynch W; Nemeh H; Mulligan M; Song T; Jessen M; Camp PC; Caldeira C; Whitson B; Kreisel D; Ramzy D; D'Ovidio F
    J Heart Lung Transplant; 2020 Sep; 39(9):954-961. PubMed ID: 32475748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK.
    Fisher A; Andreasson A; Chrysos A; Lally J; Mamasoula C; Exley C; Wilkinson J; Qian J; Watson G; Lewington O; Chadwick T; McColl E; Pearce M; Mann K; McMeekin N; Vale L; Tsui S; Yonan N; Simon A; Marczin N; Mascaro J; Dark J
    Health Technol Assess; 2016 Nov; 20(85):1-276. PubMed ID: 27897967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of donor related lung injury in clinical lung transplantation using a validated ex vivo lung perfusion inflammation score.
    Sage AT; Richard-Greenblatt M; Zhong K; Bai XH; Snow MB; Babits M; Ali A; Baciu C; Yeung JC; Liu M; Cypel M; Kain KC; Keshavjee S
    J Heart Lung Transplant; 2021 Jul; 40(7):687-695. PubMed ID: 33781664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Profile of Ex Vivo Lung Perfusate Yields Biomarkers for Lung Transplant Outcomes.
    Hsin MK; Zamel R; Cypel M; Wishart D; Han B; Keshavjee S; Liu M
    Ann Surg; 2018 Jan; 267(1):196-197. PubMed ID: 29240608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of marginal donors for lung transplantation after ex vivo lung perfusion: A systematic review and meta-analysis.
    Tian D; Wang Y; Shiiya H; Sun CB; Uemura Y; Sato M; Nakajima J
    J Thorac Cardiovasc Surg; 2020 Feb; 159(2):720-730.e6. PubMed ID: 31548078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation after ex vivo lung perfusion: A midterm follow-up.
    Wallinder A; Riise GC; Ricksten SE; Silverborn M; Dellgren G
    J Heart Lung Transplant; 2016 Nov; 35(11):1303-1310. PubMed ID: 27381674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-free DNA in human ex vivo lung perfusate as a potential biomarker to predict the risk of primary graft dysfunction in lung transplantation.
    Kanou T; Nakahira K; Choi AM; Yeung JC; Cypel M; Liu M; Keshavjee S
    J Thorac Cardiovasc Surg; 2021 Aug; 162(2):490-499.e2. PubMed ID: 32928548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CLUE for better assessment of donor lungs: Novel technique in clinical ex vivo lung perfusion.
    Ayyat KS; Okamoto T; Niikawa H; Sakanoue I; Dugar S; Latifi SQ; Lebovitz DJ; Moghekar A; McCurry KR
    J Heart Lung Transplant; 2020 Nov; 39(11):1220-1227. PubMed ID: 32773324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo lung perfusion to improve donor lung function and increase the number of organs available for transplantation.
    Valenza F; Rosso L; Coppola S; Froio S; Palleschi A; Tosi D; Mendogni P; Salice V; Ruggeri GM; Fumagalli J; Villa A; Nosotti M; Santambrogio L; Gattinoni L
    Transpl Int; 2014 Jun; 27(6):553-61. PubMed ID: 24628890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard donor lung procurement with normothermic ex vivo lung perfusion: A prospective randomized clinical trial.
    Slama A; Schillab L; Barta M; Benedek A; Mitterbauer A; Hoetzenecker K; Taghavi S; Lang G; Matilla J; Ankersmit H; Hager H; Roth G; Klepetko W; Aigner C
    J Heart Lung Transplant; 2017 Jul; 36(7):744-753. PubMed ID: 28314503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of ex vivo lung perfusion on improving organ quality and ameliorating ischemia reperfusion injury.
    Iske J; Hinze CA; Salman J; Haverich A; Tullius SG; Ius F
    Am J Transplant; 2021 Dec; 21(12):3831-3839. PubMed ID: 34355495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common Criteria for Ex Vivo Lung Perfusion Have No Significant Impact on Posttransplant Outcomes.
    Okahara S; Levvey B; McDonald M; D'Costa R; Opdam H; Pilcher DV; Snell GI
    Ann Thorac Surg; 2021 Apr; 111(4):1156-1163. PubMed ID: 32890490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact and relevance of techniques and fluids on lung injury in machine perfusion of lungs.
    Ponholzer F; Dumfarth J; Krapf C; Pircher A; Hautz T; Wolf D; Augustin F; Schneeberger S
    Front Immunol; 2024; 15():1358153. PubMed ID: 38510260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary graft dysfunction.
    Criner RN; Clausen E; Cantu E
    Curr Opin Organ Transplant; 2021 Jun; 26(3):321-327. PubMed ID: 33938469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
    Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Adhesion Molecules During Ex Vivo Lung Perfusion Are Associated With Posttransplant Primary Graft Dysfunction.
    Hashimoto K; Cypel M; Kim H; Machuca TN; Nakajima D; Chen M; Hsin MK; Zamel R; Azad S; Waddell TK; Liu M; Keshavjee S
    Am J Transplant; 2017 May; 17(5):1396-1404. PubMed ID: 27977885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and severity of primary graft dysfunction after lung transplantation using rejected grafts reconditioned with ex vivo lung perfusion.
    Boffini M; Ricci D; Bonato R; Fanelli V; Attisani M; Ribezzo M; Solidoro P; Del Sorbo L; Ranieri VM; Rinaldi M
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):789-93. PubMed ID: 25061216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Conversional Efficacy of Ex Vivo Lung Perfusion and Clinical Outcomes in Patients Undergoing Transplantation of Donor Lungs by Ex Vivo Lung Perfusion: A Meta-Analysis.
    Luo Q; Zhu L; Wang Y; Wang L; Lv W; Hu J
    Ann Transplant; 2019 Dec; 24():647-660. PubMed ID: 31879416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex Vivo Lung Perfusion Improves the Inflammatory Signaling Profile of the Porcine Donor Lung Following Transplantation.
    Stone JP; Ball AL; Crichley W; Yonan N; Liao Q; Sjöberg T; Steen S; Fildes JE
    Transplantation; 2020 Sep; 104(9):1899-1905. PubMed ID: 32502131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.